CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 45 enrolled
Drug / intervention
Lidocaine tetracaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00552695
NCT00552695Phase 2Completed
CompareCT.gov

Phase II Study of Lidoderm Patches Prior to Intravenous Catheter Insertion.

Stony Brook University·interventional·Posted Nov 2, 2007·Updated Oct 22, 2012

In Brief

A Phase 2 clinical trial evaluating Lidocaine tetracaine and Placebo for Need for Intravenous Catheter. Completed, enrolled 45 participants across 1 site.

Detailed Summary

This study will determine whether application of a patch containing a topical anesthetic (numbing medicine) named lidocaine can reduce the pain of subsequent insertion of an intravenous catheter in Emergency Department patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeed for Intravenous Catheter
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 2, 2007
Enrollment StartAug 1, 2007
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 18.7 years ago

Interventions

Lidocaine tetracainedevice

Lidocaine 70 mg/tetracaine 70 mg

Placebodevice

Placebo patch identical in appearance to Synera